Cutaneous lysate and PSP proteins are signature ingredients in Neocutis skincare, known for their powerful skin-rejuvenating effects. Neocutis uses a unique strain of fibroblast cultures to create their cutaneous lysate, setting it apart from other brands. This exclusive process results in a lysate rich in growth factors, cytokines, and antioxidants that promote skin repair and collagen production. The only other brand with similar technology is SkinMedica.

Both SkinMedica and Neocutis are reputable companies known for their high-quality sources of growth factors. Whether you're using SkinMedica's Human Fibroblast Conditioned Media or Neocutis's unique cutaneous lysate, you can trust that both brands offer advanced, effective solutions for skin rejuvenation and anti-aging.

Human Fibroblast Conditioned Media (HFCM) and cutaneous lysate are both derived from fibroblast cultures, but the key difference lies in their processing and resulting composition. HFCM, used by SkinMedica, involves isolating proteins and growth factors secreted by fibroblasts, creating a potent solution for skin rejuvenation. In contrast, Neocutis's cutaneous lysate is derived from a unique fibroblast strain, producing a rich blend of growth factors, cytokines, and antioxidants. This results in different protein compositions and effects on the skin, with cutaneous lysate offering a unique approach to anti-aging.

Neocutis, a luxury Swiss skincare brand, was founded in 2003 as a spin-off from the University Hospital of Lausanne, Switzerland. The brand was developed with significant input from dermatologists and scientists, focusing on advanced anti-aging solutions. Their signature ingredient, Processed Skin Cell Proteins (PSP), also known as cutaneous lysate, is a unique blend of growth factors, cytokines, and interleukins, designed to rejuvenate and repair the skin.

In 2013, Neocutis was acquired by Merz Pharma, a German company specializing in medical and aesthetic dermatology. (Merz is the maker of the skin tightening treatment known as Ulthera.) This acquisition strengthened Neocutis’s position in the luxury skincare market, particularly in the U.S.